Effects of quercetin and metabolites on uric acid biosynthesis and consequences for gene expression in the endothelium

Uric acid, a metabolic product of purine degradation in humans, is a risk factor for developing gout and type 2 diabetes, and supplementation with quercetin lowers plasma uric acid in mildly hyperuricemic men. Here we examined the mechanism of inhibition of enzymes involved in uric acid metabolism b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Free radical biology & medicine 2021-01, Vol.162, p.191-201
Hauptverfasser: Tumova, Sarka, Shi, Yuanlu, Carr, Ian M., Williamson, Gary
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Uric acid, a metabolic product of purine degradation in humans, is a risk factor for developing gout and type 2 diabetes, and supplementation with quercetin lowers plasma uric acid in mildly hyperuricemic men. Here we examined the mechanism of inhibition of enzymes involved in uric acid metabolism by quercetin, conjugates and microbial catabolites, and measured the effect of lowered circulating uric acid on endothelial cell gene expression. Inhibition of adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP) and xanthine oxidoreductase (XOR) activity by quercetin and metabolites was determined by HPLC. Human umbilical vein endothelial cells (HUVECs) were cultured under conditions mimicking blood flow, treated with uric acid (0, 300 or 500 μmol/L), and changes in gene expression measured using transcriptomics and quantitative droplet digital PCR. In human plasma, no inhibition of PNP activity was observed, and only quercetin weakly inhibited ADA. XOR was not present at sufficient amount in human plasma to use for testing, but quercetin, quercetin-3′-sulfate and the gut microbial metabolite 3′,4′-dihydroxyphenylacetic acid inhibited bovine milk XOR. Several changes were observed in gene expression in HUVECs under flow compared to static conditions, but after uric acid treatment, only very few changes were detected. We propose that the main mechanism by which quercetin, as quercetin-3′-sulfate, lowers uric acid in vivo is through inhibition of XOR, and not ADA nor PNP. The pertinent shift in uric acid concentration was not sufficient to produce significant changes in endothelial gene expression in a cell model. [Display omitted] •Quercetin and quercetin-3′-sulfate inhibited xanthine oxidoreductase.•The gut microbial metabolite 3′,4′-dihydroxyphenylacetic acid inhibited xanthine oxidoreductase.•No inhibition of human adenosine deaminase or purine nucleoside phosphorylase seen.•Gene expression of human endothelial cells modified by flow.•Uric acid only modestly changed gene expression in human endothelial cells.
ISSN:0891-5849
1873-4596
DOI:10.1016/j.freeradbiomed.2020.10.017